Question 1

Cell-mediated immunity (CMI): In which of the following immunologic scenarios does CMI play a central and necessary role?

Accepted Answer

Introduction / Context:Cell-mediated immunity (CMI) is driven primarily by T lymphocytes and activated macrophages rather than by circulating antibodies. Recognizing clinical settings where CMI dominates helps clinicians anticipate pathology and select appropriate diagnostic tests or therapies. Given Data / Assumptions: Delayed-type hypersensitivity (DTH) is a T cell–mediated response. Allograft rejection requires T cell recognition of foreign MHC/peptides. Graft-versus-host reaction arises from donor T cells attacking host tissues. Concept / Approach:CMI involves CD4+ Th1 cells, CD8+ cytotoxic T cells, and activated macrophages. DTH (e.g., tuberculin skin test) is a hallmark Th1-mediated reaction. Transplant immunology centers on T cell recognition leading to cytotoxicity and cytokine-mediated damage. GVH is likewise T cell driven, but initiated by donor cells in an immunocompromised host. Step-by-Step Solution: Map each listed condition to T cell–mediated mechanisms. Confirm antibody is not the primary effector in these processes. Integrate the three scenarios under the umbrella of CMI. Choose the inclusive option “All of the above.” Verification / Alternative check:Histology of rejected grafts and GVH lesions shows T cell infiltration and cytokine signatures. DTH testing relies on T cell memory rather than serum antibody levels. Why Other Options Are Wrong: Any single choice alone is incomplete. Immediate hypersensitivity only: Type I hypersensitivity is IgE-mediated and not representative of CMI. Common Pitfalls:Confusing Type II/III antibody-mediated reactions with CMI; transplant and DTH reactions are classic T cell phenomena. Final Answer:All of the above.

Question 2

Cytokines in delayed-type hypersensitivity (DTH): Which lymphokines are secreted by DTH (Th1) cells to modulate macrophage function and cell migration?

Accepted Answer

Introduction / Context:Delayed-type hypersensitivity (Type IV) reactions are orchestrated by Th1 cells that secrete cytokines to recruit, retain, and activate macrophages at the site of antigen exposure. Understanding which mediators are produced clarifies the cellular mechanisms underlying granuloma formation and tuberculin skin tests. Given Data / Assumptions: DTH involves cytokines that influence macrophage behavior and leukocyte trafficking. Nomenclature may vary, but functions include activation, stimulation, and migration inhibition. Th1 profile (e.g., IFN-gamma, IL-2) underlies these effects. Concept / Approach:Th1 cells produce interferon-gamma, which activates macrophages (macrophage activating factor effect). Additional factors historically termed migration inhibiting factor limit macrophage egress, concentrating them at the lesion. Collectively, these cytokines enhance microbicidal activity, antigen presentation, and tissue inflammation characteristic of DTH. Step-by-Step Solution: Associate Th1 cytokines with macrophage activation and retention. Recognize historical terms (e.g., MIF) describing these functions. Acknowledge overlapping nomenclature but similar functional outcomes. Select the inclusive option indicating all are secreted. Verification / Alternative check:Experimental models show that blocking IFN-gamma reduces macrophage activation and abrogates DTH lesions, underscoring the Th1 cytokine axis. Why Other Options Are Wrong: Single mediators alone do not reflect the coordinated Th1 response. Interleukin-4 only: More typical of Th2 responses, not DTH. Common Pitfalls:Assuming one cytokine is solely responsible; DTH is polycytokine-driven with synergistic effects on macrophages. Final Answer:All of the above.

Question 3

T-helper cell dysregulation: Excessive activity of helper T (Th) cells is most likely to lead to which clinical-immunological outcome?

Accepted Answer

Introduction / Context:T-helper (Th) cells coordinate immune responses by delivering help to B cells and activating macrophages and cytotoxic T cells. While essential for defense, overactive or dysregulated Th responses can break self-tolerance and drive autoimmune disease. Given Data / Assumptions: Overactivity implies heightened cytokine production and co-stimulation. Loss of regulatory balance (e.g., Treg insufficiency) is a common backdrop. Outcome of interest is pathological, not healthy optimization. Concept / Approach:Excess Th1/Th17 responses can perpetuate chronic inflammation and autoreactive lymphocyte activation, resulting in tissue damage (e.g., in rheumatoid arthritis, multiple sclerosis, psoriasis). Th cell help also accelerates class switching and affinity maturation of autoreactive B cells, amplifying autoantibody production and immune complex disease. Step-by-Step Solution: Define “overactivity” as pathologically increased Th help and cytokines. Connect this to enhanced activation of autoreactive clones. Recognize clinical manifestation: autoimmune pathology. Choose autoimmunity as the likely consequence. Verification / Alternative check:Therapies that dampen Th signaling (e.g., anti–IL-17, anti–IL-6, CTLA-4–Ig) alleviate autoimmune diseases, validating the causal role of excessive Th activity. Why Other Options Are Wrong: Optimal responses without pathology: Describe healthy regulation, not overactivity. None of the above / Immunodeficiency: Overactivity leads to inflammation and autoimmunity, not deficiency. Common Pitfalls:Ignoring the role of regulatory T cells; autoimmunity often reflects imbalance between effector Th and Treg compartments. Final Answer:Autoimmunity.

Question 4

Therapeutic immunology: Which of the following are used clinically as immunosuppressive agents to dampen unwanted immune responses (e.g., after transplantation or in autoimmune disease)?

Accepted Answer

Introduction / Context:Immunosuppressive therapies are essential to prevent transplant rejection and to treat autoimmune and inflammatory disorders. Different agents act at distinct points in lymphocyte activation, proliferation, or survival. Given Data / Assumptions: We are considering standard clinical agents that reduce immune activity. Multiple drug classes with different mechanisms exist. Choice focuses on whether each listed item is used for immunosuppression. Concept / Approach:Cyclosporine inhibits calcineurin, blocking IL-2 transcription and T cell activation. Methotrexate, at immunomodulatory doses, inhibits folate-dependent pathways and exerts anti-proliferative and anti-inflammatory effects (elevates adenosine), widely used in rheumatology. Anti-lymphocytic (anti-thymocyte) serum contains polyclonal antibodies that deplete T cells, used in transplant induction or rejection episodes. Step-by-Step Solution: Evaluate each agent's known immunosuppressive mechanism. Confirm clinical use in transplantation or autoimmunity. Recognize that all three qualify as immunosuppressants. Select “All of these.” Verification / Alternative check:Guidelines for solid-organ transplantation and autoimmune disease management list these agents among recommended therapies, confirming their immunosuppressive status. Why Other Options Are Wrong: Any single option omits other valid agents. Erythropoietin only: Primarily hematopoietic; not an immunosuppressant. Common Pitfalls:Assuming methotrexate is purely chemotherapeutic; at low doses it is a mainstay disease-modifying antirheumatic drug with immunomodulatory effects. Final Answer:All of these.

Question 5

Immunological tolerance: Which mechanisms contribute to the induction and maintenance of immunological tolerance to self antigens?

Accepted Answer

Introduction / Context:Immunological tolerance prevents destructive responses against self tissues. Multiple, non-redundant mechanisms operate at different stages of lymphocyte development and activation to enforce self-tolerance and avert autoimmunity. Given Data / Assumptions: Tolerance occurs centrally (thymus/bone marrow) and peripherally (secondary lymphoid tissues). Mechanisms may delete, silence, or actively suppress self-reactive lymphocytes. Physiologic conditions are considered, not experimental ablations. Concept / Approach:Clonal deletion removes strongly self-reactive T and B cells during development (negative selection) or in the periphery via apoptosis. Clonal anergy renders lymphocytes unresponsive when antigen is encountered without adequate co-stimulation or in the presence of inhibitory signals. Suppression by regulatory T cells (Treg) actively maintains tolerance through cytokines (e.g., IL-10, TGF-beta), metabolic disruption, and inhibitory receptor engagement. Step-by-Step Solution: Enumerate the main tolerance mechanisms: deletion, anergy, suppression. Associate each with its operational context (central vs. peripheral). Recognize their complementary roles in preventing autoimmunity. Choose the inclusive option indicating all mechanisms contribute. Verification / Alternative check:Genetic defects in Treg pathways (e.g., FOXP3) or failures in deletion/anergy correlate with severe autoimmune syndromes, underscoring the necessity of all three strategies. Why Other Options Are Wrong: Any single mechanism alone is insufficient to explain physiological tolerance breadth. Somatic hypermutation only: Increases antibody affinity; does not induce tolerance. Common Pitfalls:Overemphasizing central deletion while neglecting peripheral regulation; self-tolerance is safeguarded at multiple checkpoints. Final Answer:All of these.

Question 6

Immunology – identifying the negative phase In immunology, the phenomenon known as the “negative phase,” which represents a transient fall in antibody levels immediately after antigen exposure, is most prominently observed in which type of humoral i…

Accepted Answer

Introduction / Context:The immune system exhibits different patterns of antibody response depending on whether the body is encountering an antigen for the first time (primary response) or during subsequent exposures (secondary response). A key phenomenon to understand is the “negative phase,” which refers to an initial dip in circulating antibody levels after antigen introduction. Given Data / Assumptions: Antibody titers can fluctuate after antigen administration. Primary responses differ from secondary in timing and magnitude. Negative phase describes the short period of antibody decline before synthesis of new antibodies begins. Concept / Approach:In the primary immune response, existing natural antibodies (low-affinity IgM) may bind the introduced antigen, forming immune complexes. This temporarily reduces measurable free antibody levels, producing the negative phase. Later, B-cell activation and clonal expansion lead to rising IgM and IgG levels. In secondary responses, memory B cells rapidly generate antibodies, typically masking or eliminating any negative phase. Step-by-Step Solution:Step 1: Define negative phase = transient decline in antibody titer post-antigen exposure.Step 2: Link to mechanism: antigen binding clears pre-existing antibodies.Step 3: Identify context: occurs during first exposure, i.e., primary humoral response.Step 4: Conclude that the correct answer is “Primary humoral response.” Verification / Alternative check:Experimental antibody titer curves show a brief dip in antibody concentration before the classic lag, log, plateau, and decline phases of the primary response. Why Other Options Are Wrong: Secondary response: rapid IgG rise, no clear negative phase. Both: not correct; it is characteristic of the primary response. None: incorrect, because the negative phase is well-documented in primary responses. CMI only: irrelevant; negative phase refers specifically to antibody titers. Common Pitfalls:Confusing the “lag phase” with the “negative phase.” The lag phase is the delay before antibody increase, while the negative phase specifically refers to the transient decline in circulating antibodies. Final Answer:Primary humoral response.

Question 7

Immunology – classification of eye lens antigens Lens antigens of the eye, which are normally hidden from immune recognition under physiological conditions, are best described as:

Accepted Answer

Introduction / Context:Certain body sites (eye, brain, testis) are immunologically privileged, meaning their antigens are isolated from the immune system under normal conditions. Eye lens proteins provide a classical example. Given Data / Assumptions: Lens proteins are not normally exposed to immune surveillance. Exposure may occur after trauma or surgery. Immune response against these antigens may lead to autoimmunity. Concept / Approach:Sequestrated antigens are hidden (sequestered) in anatomical locations without lymphatic drainage or exposure. When released, they can be recognized as “foreign” by the immune system despite being self-antigens, provoking autoimmunity. This is distinct from cross-reacting antigens (shared epitopes with microbes) and neoantigens (new epitopes created by mutation or chemical alteration). Step-by-Step Solution:Step 1: Define sequestrated antigens as self-antigens normally hidden from immune system.Step 2: Identify lens proteins as such an example.Step 3: Select “Sequestrated antigens” as correct. Verification / Alternative check:Clinical examples include sympathetic ophthalmia, an autoimmune condition triggered by lens antigen exposure following ocular injury. Why Other Options Are Wrong: Cross-reacting antigens: involve mimicry with microbial epitopes, not sequestration. Neoantigens: result from mutations or modifications, not anatomical sequestration. None: incorrect because sequestration is a well-established category. Self-antigens with molecular mimicry: different mechanism, not sequestration. Common Pitfalls:Confusing sequestrated with cross-reactive antigens; only sequestrated antigens are physically hidden from immune surveillance. Final Answer:Sequestrated antigens.

Question 8

Autoimmune diseases – recognizing classic examples Which of the following conditions are recognized examples of autoimmune disease in clinical immunology?

Accepted Answer

Introduction / Context:Autoimmune diseases arise when the immune system loses tolerance to self-antigens and mounts pathogenic responses against host tissues. Recognizing prototypical examples is essential for clinicians, microbiologists, and exam candidates. Given Data / Assumptions: Autoimmunity includes organ-specific and systemic disorders. Multiple immune mechanisms may be involved (autoantibodies, immune complexes, T-cell–mediated injury). The listed conditions are common textbook entities. Concept / Approach:Rheumatoid arthritis involves autoantibodies (e.g., rheumatoid factor, anti-CCP) and synovial inflammation. Systemic lupus erythematosus is a systemic immune complex disease with diverse autoantibodies (ANA, anti-dsDNA, anti-Sm). Polyarteritis nodosa is a necrotizing vasculitis of medium-sized arteries often associated with immune-mediated injury. Because each is a well-established autoimmune disorder, the inclusive option is correct. Step-by-Step Solution:Identify each listed disease and its autoimmune basis.Confirm that all three are standard autoimmune exemplars.Select “All of the above.” Verification / Alternative check:Standard rheumatology and immunology texts classify RA, SLE, and PAN as autoimmune, supporting the selection. Why Other Options Are Wrong: Individual options (RA, SLE, PAN) are correct but incomplete. “None” contradicts established nosology. Common Pitfalls:Confusing PAN with ANCA-associated vasculitides; PAN is classically ANCA-negative but still immune-mediated and placed within autoimmune/immune complex disorders. Final Answer:All of the above.

Question 9

Assessing cell-mediated immunity (CMI) Which of the following laboratory or clinical methods can be used to detect or evaluate T-cell–mediated (cell-mediated) immune responses in humans?

Accepted Answer

Introduction / Context:Cell-mediated immunity (CMI) encompasses T-cell effector functions such as delayed-type hypersensitivity, macrophage activation, and cytotoxic T-lymphocyte (CTL)–mediated lysis. Measuring CMI is important in diagnosing infections, immune deficiencies, and vaccine take. Given Data / Assumptions: CMI testing focuses on T-cell–dependent reactions. Both in vivo and in vitro methods exist. Humoral assays alone do not directly reflect CMI. Concept / Approach:Migration inhibition assays measure lymphokine-mediated suppression of leukocyte migration. CTL assays quantify target cell killing by antigen-specific T cells. Delayed-type hypersensitivity skin tests (e.g., PPD) reflect antigen-specific memory T-cell activity in vivo. Because all three evaluate T-cell–dependent responses, the most inclusive answer is correct. Step-by-Step Solution:Map each method to a T-cell function (cytokine release, cytotoxicity, DTH).Recognize that each provides evidence of CMI.Choose “All of the above.” Verification / Alternative check:Clinical immunology practice routinely uses DTH skin testing; research labs employ CTL assays and migration inhibition as functional readouts. Why Other Options Are Wrong: Each single method is valid but incomplete alone. Complement fixation assesses antibodies and complement activation, not CMI. Common Pitfalls:Equating antibody titers with CMI; humoral immunity is distinct from T-cell–mediated mechanisms. Final Answer:All of the above.

Question 10

Role of plasma cells in humoral immunity  What do plasma cells produce in large quantities for release into the bloodstream?

Accepted Answer

Introduction:Plasma cells are terminally differentiated B lymphocytes specialized for high-rate antibody secretion. Their function underpins humoral immunity, neutralization, opsonization, and complement activation. Given Data / Assumptions: Plasma cells arise after B cell activation and differentiation. They expand rough endoplasmic reticulum and Golgi for protein secretion. Secreted product is immunoglobulin (antibody) specific to the initiating antigen. Concept / Approach: Identify the effector molecule produced by plasma cells. Antibodies circulate to bind antigens, block pathogen entry, and recruit effector mechanisms via Fc regions. Step-by-Step Solution: 1) B cell recognizes antigen and receives T cell help.2) Germinal center reactions refine affinity and isotype.3) Differentiation yields plasma cells that secrete immunoglobulins.4) Antibodies enter blood and tissues to mediate protection. Verification / Alternative check: Serum immunoglobulin spikes after vaccination or infection mirror plasma cell activity. Why Other Options Are Wrong: Option A: Antigens are foreign substances, not produced by plasma cells. Option C: Helper T cells arise from T lineage, not B cell differentiation. Option D: Virus fragments may be present during infection but are not plasma cell products. Option E: Plasma cells secrete large amounts of immunoglobulins; cytokines may be produced by other immune cells. Common Pitfalls: Confusing antibody production (B lineage) with cytokine-focused T cell functions. Final Answer: Antibodies

Question 11

What accumulates in lymph nodes during an active viral infection?  Identify the best description of the contents and structures present.

Accepted Answer

Introduction:Lymph nodes are hubs for immune surveillance and response. During infections like the common cold, nodes enlarge due to cellular recruitment and proliferation, while lymph-borne antigens and pathogens are filtered and retained. Given Data / Assumptions: Nodes receive afferent lymph containing antigens, pathogens, and dendritic cells. Germinal centers form with proliferating B cells and helper T cells. Anatomical lymphatic vessels enter and exit nodes. Concept / Approach: All listed features coexist during active responses: abundant leukocytes, trapped antigens/pathogens, and the lymphatic conduits that shuttle lymph through the node’s architecture. Step-by-Step Solution: 1) Recognize node swelling results from leukocyte accumulation and proliferation.2) Understand that subcapsular sinuses filter lymph, capturing virus/antigen.3) Note the structural presence of afferent/efferent lymphatics and continuous lymph flow.4) Therefore, the inclusive option listing all three is correct. Verification / Alternative check: Histology and imaging show increased cellularity, antigen deposition on follicular dendritic cells, and well-defined lymphatic vessels during infections. Why Other Options Are Wrong: Options A, B, C each capture part of the truth but are incomplete alone. Option E: Red blood cells are not typical residents; nodes are lymphoid, not hematologic filtration organs like the spleen. Common Pitfalls: Confusing lymph nodes with spleen (blood-borne antigen) or assuming nodes only contain fluid without significant cellular dynamics. Final Answer: All of the above

Question 12

Definition and purpose of vaccines  Solutions prepared from weakened or dead microorganisms, viruses, or toxins that provide protective immunity are called what?

Accepted Answer

Introduction:Vaccines are biological preparations that train the immune system to recognize and neutralize pathogens or their toxins. They can contain attenuated organisms, inactivated organisms, subunits, toxoids, or genetic platforms that express antigen in vivo. Given Data / Assumptions: Formulation includes weakened (attenuated) or dead microbes, or toxoids. Goal is to induce protective immunity and immunological memory. Preparations are administered prophylactically, not to directly kill pathogens like antibiotics do. Concept / Approach: The defining feature of a vaccine is its capacity to stimulate adaptive immunity (antibodies, T cells) without causing the disease state, thereby preventing future infection or severe disease. Step-by-Step Solution: 1) Identify the composition as attenuated/inactivated microbe or toxin derivative.2) Recognize the intended outcome: immune priming and memory.3) Name the preparation according to immunology/medicine standards: vaccine. Verification / Alternative check: Public health practice and pharmacology texts define vaccines exactly in this way; examples include measles (attenuated), IPV (inactivated), and tetanus toxoid (toxin-derived). Why Other Options Are Wrong: Option B: Histamine is a mediator, not a prophylactic biological. Option C: “Drugs” is too broad and not specific to immunization. Option D: Antibiotics act against bacteria directly; they are not vaccines. Option E: Diagnostic serums are used for tests, not for inducing immunity. Common Pitfalls: Equating antibiotics with vaccines; they serve very different roles—therapy vs prevention. Final Answer: Vaccines

Question 13

Complement activation without antibodies  Polysaccharides on microbial surfaces can directly activate the complement system in the absence of antibodies via which pathway?

Accepted Answer

Introduction:The complement system can be triggered by multiple pathways to enhance pathogen clearance. Not all pathways require antibodies; this question focuses on antibody-independent mechanisms on microbial surfaces. Given Data / Assumptions: Microbial polysaccharides and other surface patterns can promote spontaneous C3 hydrolysis and deposition. The alternative pathway amplifies complement activation on susceptible surfaces without antibodies. The classical pathway usually requires antigen–antibody complexes. Concept / Approach: Spontaneous C3 “tickover” produces C3b that can covalently attach to microbial surfaces. Properdin and factor B/D stabilize convertases on non-host surfaces, leading to opsonization and membrane attack complex formation independently of antibodies. Step-by-Step Solution: 1) Identify the pathway that does not require antibody: alternative pathway.2) Recognize microbial polysaccharides as permissive surfaces for C3b deposition.3) Stabilize C3 convertase (C3bBb) with properdin, driving complement cascade.4) Conclude antibody independence for activation on such surfaces. Verification / Alternative check: Immunology references describe alternative pathway activation on bacteria, fungi, and some viruses without pre-existing antibodies, contributing to early innate defense. Why Other Options Are Wrong: Option B/E: These incorrectly impose antibody requirements typical of the classical pathway. Option C: “Metabolic pathway” is not a complement activation mechanism. Option D: Incorrect because a valid pathway exists (alternative pathway). Common Pitfalls: Assuming complement always needs antibodies; overlooking lectin and alternative pathways that act early in infection. Final Answer: Antibody-independent activation via the alternative pathway

Question 14

Human immunology — After a person was vaccinated in the past (no current infection), which component is most reliably present now as long-term protection?

Accepted Answer

Introduction:Vaccination trains the adaptive immune system to respond rapidly on re-exposure. This question probes what long-term immune component typically persists after a prior immunization when there is no current infection. Given Data / Assumptions: Vaccination occurred sometime in the past; there is no ongoing disease. Common vaccine types (inactivated, subunit, toxoid, conjugate, or live-attenuated) may have been used. Question asks for the component most reliably present now. Concept / Approach:Following immunization, the primary response generates short-lived effector cells and antibodies, and critically, long-lived memory B cells (and memory T cells). Serum antibody titers may wane over time, but memory B cells persist and can rapidly differentiate into plasma cells upon re-exposure, producing high-affinity antibodies. Step-by-Step Solution: 1) Identify durable element: memory B cells persist for years to decades and are a cornerstone of vaccine efficacy.2) Consider antibody levels: IgG titers often decline months to years after vaccination; some vaccines need boosters.3) Consider pathogen/antigen presence: except for limited persistence of some live-attenuated vaccines early after dosing, the disease organism is not chronically present.4) Therefore, the most reliable long-term component is memory B lymphocytes specific to the vaccine antigen. Verification / Alternative check:Booster doses rapidly raise titers due to swift activation and clonal expansion of memory B cells and their differentiation into antibody-secreting plasma cells, confirming their durable presence after priming. Why Other Options Are Wrong: The disease organism itself and its antigens: not expected after routine vaccination; persistence would imply infection. Very high persistent antibodies in all cases: titers often wane; not guaranteed without boosters. All of the above: includes incorrect statements. Live vaccine virus actively replicating indefinitely: live-attenuated strains do not replicate forever; chronic replication is not normal. Common Pitfalls:Equating serologic titer persistence with protection. Memory B cells can provide rapid secondary responses even when baseline titers are low. Final Answer:Memory B lymphocytes specific for the antigen from this disease organism.

Question 15

Vaccinology — The immune response triggered by a booster (repeat) vaccine dose is called what?

Accepted Answer

Introduction:Booster vaccinations exploit immunological memory to elicit a faster and stronger reaction than the initial dose. This question asks for the correct term describing that memory-driven reaction. Given Data / Assumptions: A prior priming dose has already been received. The booster is administered after memory has formed. Standard immunology terminology is used. Concept / Approach:An initial exposure leads to a primary response (lag, lower magnitude, more IgM). Upon re-exposure to the same antigen, memory B and T cells mount a secondary response (shorter lag, higher magnitude, affinity-matured IgG predominance). Step-by-Step Solution: 1) Identify context: prior exposure exists → memory cells are present.2) Memory activation produces faster, higher-affinity antibodies and more robust effector function.3) The correct term for this phenomenon is the secondary response. Verification / Alternative check:Serology shows rapid IgG rise after boosters compared with the slower, IgM-skewed primary response after first exposure. Why Other Options Are Wrong: Cellular response: a modality (T-cell mediated), not a phase designation. Innate response: occurs immediately and non-specifically, not booster-specific. Primary response: refers to first exposure. Humoral response: a branch (antibody-mediated), not the timing descriptor. Common Pitfalls:Confusing response type (humoral vs cellular) with response order (primary vs secondary). Final Answer:secondary response.

Question 16

Cell-mediated immunity — Which T lymphocytes recognize and kill infected or foreign cells?

Accepted Answer

Introduction:Cell-mediated immunity eliminates infected or altered self cells through specialized effector T cells. This question checks your understanding of terminology describing the cytolytic T-cell subset. Given Data / Assumptions: Focus is on T-cell types involved in direct killing. Standard immunology nomenclature. Effector mechanisms include perforin/granzyme and Fas–FasL pathways. Concept / Approach:Cytotoxic T lymphocytes (CD8+) are commonly called killer T cells. They recognize peptides presented by MHC I on target cells and induce apoptosis to clear intracellular pathogens or malignant cells. Step-by-Step Solution: 1) Map terms: CTL and killer T cells refer to the same functional subset (CD8+).2) Identify role: recognition via TCR–peptide–MHC I → delivery of lethal hit.3) Therefore, both (a) and (b) are correct. Verification / Alternative check:Experimental assays (e.g., chromium release, flow cytometric killing assays) demonstrate specific lysis mediated by CD8+ CTLs against peptide-pulsed targets. Why Other Options Are Wrong: None of the above: contradicts standard definitions. Memory B lymphocytes: mediate humoral memory, not cytolysis. Common Pitfalls:Confusing CTLs (CD8+) with NK cells (innate-like cytotoxicity) or with helper T cells (CD4+). Final Answer:both (a) and (b).

Question 17

Measuring humoral immunity — Which laboratory metric detects a humoral response to influenza virus?

Accepted Answer

Introduction:Humoral immunity refers to antibody-mediated protection. This question asks which laboratory measurement best reflects a humoral response after exposure or vaccination against influenza virus. Given Data / Assumptions: Influenza infection or vaccination context. Standard clinical and research assays. Goal: detect antibody presence/levels. Concept / Approach:Humoral responses are quantified by measuring antigen-specific antibodies in serum (e.g., ELISA, hemagglutination inhibition titer, neutralization assays). These correlate with protection and vaccine efficacy in many settings. Step-by-Step Solution: 1) Identify humoral hallmark: antigen-specific antibodies in blood.2) Choose the direct measure: serum antibody titer provides quantitative evidence of humoral response.3) Other listed assays primarily reflect cellular immunity or nonspecific inflammation. Verification / Alternative check:Vaccine trials commonly use hemagglutination inhibition titers against influenza antigens as correlates of protection, confirming their role as humoral markers. Why Other Options Are Wrong: Cytotoxicity assays: measure cell-mediated killing by CTLs or NK cells. Dividing T cells: indicates cellular proliferation, not antibodies. Plasma cytokines: nonspecific; do not directly quantify antigen-specific antibodies. TCR repertoire: characterizes T-cell diversity, not humoral titers. Common Pitfalls:Assuming any immune assay reflects humoral function; only serum antibody measurements directly quantify the antibody arm. Final Answer:serum antibody titer.

Question 18

Immunogenicity — Which statement best defines the property that enables an antigen to elicit an immune response?

Accepted Answer

Introduction:Immunogenicity is the capacity of a substance to provoke an adaptive immune response. This question distinguishes correct determinants of immunogenicity from common misconceptions about self antigens, haptens, and antigen types. Given Data / Assumptions: Standard vertebrate adaptive immunity with T-cell help. Antigens may be proteins, polysaccharides, or other molecules. Processing and presentation via MHC are central for most T-dependent responses. Concept / Approach:Effective immunogens are typically foreign, sufficiently large and complex, and able to be processed into peptides that bind MHC for T-cell recognition. Haptens alone are not immunogenic but become so when conjugated to carriers that provide T-cell epitopes. Self antigens are ordinarily non-immunogenic due to tolerance. Step-by-Step Solution: 1) Identify key requirement: presentation to T cells via MHC enables help and robust responses.2) Evaluate self antigens: normally tolerated and non-immunogenic.3) Consider antibodies and haptens: antibodies can be immunogenic in a different species; haptens require carriers.4) Therefore, dependence on MHC-mediated presentation best defines immunogenicity. Verification / Alternative check:Carrier–hapten experiments show that small molecules become immunogenic when linked to a protein carrier providing peptides that bind MHC, confirming the centrality of T-cell recognition. Why Other Options Are Wrong: Usually a property of self antigens: false under normal tolerance. Never a property of antibodies: false; foreign immunoglobulins are immunogenic across species. Never associated with haptens even with carriers: false; hapten–carrier conjugates are classic immunogens. Only carbohydrates: false; proteins are often the most potent immunogens. Common Pitfalls:Confusing antigenicity (ability to bind antibodies) with immunogenicity (ability to induce an immune response). Final Answer:It depends on the ability of the native antigen to be processed and presented by MHC to T cells.

Question 19

Clinical immunology — Which immune cell type is especially depleted in advanced AIDS, explaining many opportunistic infections?

Accepted Answer

Introduction:Acquired immunodeficiency syndrome (AIDS) results from chronic HIV infection and progressive immune collapse. This question asks which lymphocyte subset is characteristically reduced to low counts in advanced disease. Given Data / Assumptions: Advanced HIV infection with opportunistic infections present. Typical laboratory monitoring (CD4 counts, viral load). Pathophysiology of HIV tropism. Concept / Approach:HIV targets CD4+ helper T cells, using CD4 as a receptor along with chemokine coreceptors. Progressive depletion of CD4+ cells impairs both humoral and cellular arms by removing essential helper function for B cells and CD8+ T-cell responses. Step-by-Step Solution: 1) Identify viral tropism: CD4 is the primary receptor on helper T cells.2) Recognize clinical marker: low absolute CD4 count strongly predicts opportunistic infections.3) Therefore, helper T lymphocytes (CD4+) are the most depleted subset in advanced AIDS. Verification / Alternative check:Guidelines use CD4 thresholds (e.g., 200 cells/µL) to trigger prophylaxis for opportunistic infections, illustrating the central role of CD4 depletion. Why Other Options Are Wrong: CD8+ killer T cells: may be relatively preserved early; the hallmark is CD4 loss. B cells: dysregulated but not the defining depleted subset. None of these: incorrect; CD4+ loss is well established. NK cells: function may be altered, but profound CD4 depletion defines AIDS. Common Pitfalls:Assuming cytotoxicity alone determines susceptibility; without CD4 help, many immune functions fail despite CD8 presence. Final Answer:Helper T lymphocyte (CD4+).

Question 20

Complement activation — Antibodies bound to a microorganism typically initiate which complement pathway?

Accepted Answer

Introduction:The complement system amplifies innate and adaptive immunity. This question asks which complement pathway is triggered when antibodies bind to the surface of a pathogen. Given Data / Assumptions: Antibodies (IgM or certain IgG subclasses) are bound to microbial surfaces. Goal is to identify the initiating pathway. Standard complement pathways: classical, lectin, and alternative. Concept / Approach:When antibodies bind antigens on a pathogen, the Fc regions cluster and bind C1q, activating the classical pathway cascade (C1r, C1s → C4, C2 → C3 convertase). This pathway links adaptive humoral immunity to complement effector functions such as opsonization and lysis. Step-by-Step Solution: 1) Recognize antibody requirement: classical pathway uniquely uses antibody-Fc recognition by C1q.2) Follow the cascade: C1 activation → C4b2a → C3b deposition.3) Conclude that antibody-coated microbes activate the classical pathway. Verification / Alternative check:IgM is especially efficient because a single pentamer binds C1q strongly upon antigen binding, explaining strong classical activation after IgM responses. Why Other Options Are Wrong: Metabolic, Embden–Meyerhof, Entner–Doudoroff: these are carbohydrate catabolic pathways in cells, unrelated to complement. Alternative pathway: can activate on microbial surfaces without antibody; not the antibody-triggered route. Common Pitfalls:Equating any complement activation with the alternative pathway; antibody involvement specifically indicates the classical pathway. Final Answer:classical pathway.

Immune Response Questions

Questions

Practice smarter